D. Western Therapeutics Institute Inc
Research D. Western Therapeutics Institute Inc (6DW) on Bullrun: market cap EUR 22.26M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker6DW
- ExchangeF
- CountryJapan
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 22.26M
- Financial periodFY2025
- RevenueJPY 387.62M
- Revenue growth-17.8%
- Net income-JPY 632.09M
- Free cash flow-JPY 496.54M
- Gross margin90.0%
Valuation Snapshot
latest market cap is EUR 22.26M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | JPY 387.62M | -JPY 632.09M | -JPY 496.54M | 90.0% | -13.19 | JPY 1.71B | JPY 605.18M | JPY 1.44B |
| FY2024 | JPY 471.58M | -JPY 1.29B | -JPY 1.31B | 90.1% | -36.74 | JPY 1.13B | JPY 797.98M | JPY 733.87M |
| FY2023 | JPY 428.36M | -JPY 812.41M | -JPY 601.76M | 91.4% | -25.56 | JPY 1.87B | JPY 885.12M | JPY 1.28B |
| FY2022 | JPY 448.10M | -JPY 429.69M | -JPY 364.58M | 93.8% | -14.5 | JPY 2.33B | JPY 967.69M | JPY 1.86B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-14 | EUR 22.26M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About D. Western Therapeutics Institute Inc
D. Western Therapeutics Institute, Inc., a biotechnology company, focuses on discovery and development of various drugs. It offers GLANATEC and GLA-ALPHA, an ophthalmic solution for the treatment of glaucoma/ocular hypertension; H-1337, a multi-kinase inhibitor that has started Phase IIb clinical trials for the treatment of glaucoma/ocular hypertension; DW-1001, an ophthalmic drug; and DW-1002, an ophthalmic surgical adjuvant for cataract surgeries, and ILM, ALC, ERM, and PVR membrane staining.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is D. Western Therapeutics Institute Inc's market cap?
D. Western Therapeutics Institute Inc's market capitalization is EUR 22.26M.
What does D. Western Therapeutics Institute Inc do?
D. Western Therapeutics Institute, Inc., a biotechnology company, focuses on discovery and development of various drugs. It offers GLANATEC and GLA-ALPHA, an ophthalmic solution for the treatment of glaucoma/ocular hypertension; H-1337, a multi-kinase inhibitor that has started Phase IIb clinical trials for the treatment of glaucoma/ocular hypertension; DW-1001, an ophthalmic drug; and DW-1002, an ophthalmic surgical adjuvant for cataract surgeries, and ILM, ALC, ERM, and PVR membrane staining.